MétaCan
← all works

Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target

2020· article· en· 2,822 citations· W3010126769 on OpenAlex· 10.1007/s00134-020-05985-9

Why is this work in the frame?

A frame that forgets how it found something cannot be audited. These are the routes that admitted this work.

Canadian affiliationAn author listed a Canadian institution. This is the only route the usual frame has.
Canadian funderA Canadian agency funded it. The work may carry no Canadian affiliation at all.

Abstract

A novel infectious disease, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was detected in Wuhan, China, in December 2019.The disease (COVID-19) spread rapidly, reaching epidemic proportions in China, and has been found in 27 other countries.As of February 27, 2020, over 82,000 cases of COVID-19 were reported, with > 2800 deaths.No specific therapeutics are available, and current management includes travel restrictions, patient isolation, and supportive medical care.There are a number of pharmaceuticals already being tested [1, 2], but a better understanding of the underlying pathobiology is required.In this context, this article will briefly review the rationale for angiotensin-converting enzyme 2 (ACE2) receptor as a specific target.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

The record

Venue
Intensive Care Medicine
Topic
SARS-CoV-2 and COVID-19 Research
Field
Medicine
Canadian institutions
University of British ColumbiaArtificial Intelligence in Medicine (Canada)University of TorontoSt. Michael's Hospital
Funders
Institute of Circulatory and Respiratory HealthCanadian Institutes of Health ResearchGuangzhou Regenerative Medicine and Health Guangdong LaboratoryNational Natural Science Foundation of ChinaNational Science Foundation
Keywords
MedicineAngiotensin-converting enzyme 2Peptidyl-Dipeptidase ASevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Pain medicineCoronavirus disease 2019 (COVID-19)2019-20 coronavirus outbreakAnesthesiologyAngiotensin-converting enzymeRenin–angiotensin systemReceptorEnzymePharmacologyInternal medicineVirologyAnesthesiaBlood pressureBiochemistryDiseaseBiologyInfectious disease (medical specialty)
Has abstract in OpenAlex
yes